El Salvador

Reimbursed Care Access

El Salvador maintains a restrictive drug-control framework that treats classical psychedelics and many novel psychoactive hallucinogens as prohibited ‘‘alucinógenos’’ except where strictly authorized for research or regulated medical uses. Ketamine is an established medical anesthetic and appears on public-sector medicine lists, but specialized psychedelic medicines (e.g., psilocybin, MDMA, DMT derivatives, ibogaine, 2C-X, mescaline outside specified plant/ritual contexts) have no routine medical reimbursement and are effectively limited to authorized research or are treated as controlled substances under national law. Public health insurance does not provide routine coverage for psychedelic-assisted therapies or proprietary products like esketamine (Spravato®) absent explicit registration and inclusion in national formularies.